Coston McIsaac & Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62K Hold
149
0.01% 303
2026
Q1
$40K Hold
149
0.01% 357
2025
Q4
$49K Sell
149
-12
-7% -$4.07K 0.01% 321
2025
Q3
$55K Buy
161
+8
+5% +$2.42K 0.01% 293
2025
Q2
$47K Sell
153
-17
-10% -$6.5K 0.01% 308
2025
Q1
$89K Hold
170
0.03% 206
2024
Q4
$86K Hold
170
0.03% 207
2024
Q3
$99K Hold
170
0.03% 188
2024
Q2
$86K Buy
170
+1
+0.6% +$490 0.03% 194
2024
Q1
$84K Hold
169
0.03% 198
2023
Q4
$89K Hold
169
0.03% 186
2023
Q3
$85K Buy
169
+6
+4% +$2.95K 0.03% 183
2023
Q2
$78K Hold
163
0.03% 207
2023
Q1
$77K Sell
163
-10
-6% -$4.83K 0.03% 204
2022
Q4
$92K Hold
173
0.04% 181
2022
Q3
$87K Sell
173
-1
-0.6% -$526 0.04% 158
2022
Q2
$89K Buy
+174
New +$87.4K 0.05% 99

Other funds holding UNH

Coston McIsaac & Partners's UNH Position: Q2 2026 in Review

Coston McIsaac & Partners held its UnitedHealth (UNH) position steady in Q2 2026 at 149 shares worth $62K. The position accounts for 0.01% of the portfolio, ranked #303.

Coston McIsaac & Partners first reported a position in UNH in Q2 2022 and has held it in 17 quarters since. The position peaked at $99K in Q3 2024. 3,367 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Coston McIsaac & Partners held 149 shares of UnitedHealth worth $62K as of Q2 2026.
  • Coston McIsaac & Partners left its UnitedHealth share count unchanged in Q2 2026.
  • UnitedHealth made up 0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #303 holding.
  • Coston McIsaac & Partners first reported a position in UnitedHealth in Q2 2022 and has held it in 17 quarters since.
  • Coston McIsaac & Partners's UnitedHealth position peaked at $99K in Q3 2024.
  • 3,367 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.